Wasp Stings Follow-up

  • Author: Carl A Mealie, MD, FACEP, FAAEM; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Feb 4, 2011
 

Further Inpatient Care

All patients who present with a moderate-to-severe reaction to a wasp sting that required treatment should be observed. A rebound or biphasic reaction has been reported in 1-20% of patients as initial treatment wears off.

Airway

Proactively treat patients who experience throat tightness resulting from a wasp sting. A treatment spectrum progresses from the asymptomatic patient to the patient with symptoms of mild throat tightness to the patient in respiratory distress from angioedema.

Assess the airway as soon as possible in the patient who experiences throat tightness. Although cross-lateral neck radiography to assess soft tissue can be helpful to rule out gross swelling, it has several disadvantages. It may not reveal early swelling. If transferred to the radiology department for the radiograph, the patient should be accompanied by both an intubation tray and a physician capable of managing the airway.

The airway is best visualized by either an otorhinolaryngologist or an emergency department (ED) physician using a Machida scope or, if a flexible fiberoptic scope is not available, indirect laryngoscopy. An intubation tray must be available at the bedside.

Supplemental oxygen supplied by a humidified cool mist is often helpful in the patient with minimal inflammation who does not need immediate intubation and is being observed.

Breathing

Continually monitor patients with pulse oximetry. Peak flow measurement may help evaluate the progression of bronchial spasm.

Evidence of poor ventilation with decreasing oxygen saturations, poor air movement, wheezing, poor air exchange, prolongation of the expiratory phase, or increased work of breathing requires aggressive management.

A nebulized beta agonist (eg, albuterol) can reduce bronchial spasm and improve oxygenation.

Use methylprednisolone 125 mg IV to decrease the inflammatory response of the airways.

Circulation

The cardiac rate and rhythm and the intravascular fluid compartment are 2 components of circulation that must be monitored.

Put the patient on a cardiac monitor and observe in an area where the patient can be intubated if necessary.

The BP must be monitored continuously because of the release of multiple factors in anaphylaxis that can reduce capillary integrity, increase capillary permeability, and subsequently decrease the amount of fluid in the vascular compartment and, at the same time, decrease the systemic vascular resistance.

Next

Further Outpatient Care

  • Direct outpatient care at preventing any further reaction.
  • Provide patient education to reduce high-risk activities that may lead to exposure (see Activity).
  • Prescribe self-administered auto-injectors (eg, EpiPen) to patients who have the potential for a severe reaction or who may be away from readily available medical assistance.
  • Refer patients to an allergist for desensitization. This follow-up referral should be made expeditiously. The factors to consider are include initial reaction of the patient and the patient's risk of being stung again, such as the patient's occupation and time of year.
Previous
Next

Inpatient & Outpatient Medications

  • Auto-injectors (eg, EpiPen): Patients should be taught the use of the EpiPen 0.3 mg auto-injector or the EpiPen Jr 0.15 mg before they leave the ED. The patient should be taught the indications for the use of the EpiPen such as the signs and symptoms of a severe allergic or anaphylactic reaction. They should be taught to inject the EpiPen into the anterolateral aspect of the thigh and that once the auto-injector is triggered to maintain the auto-injector in place for several seconds until all the medication is injected. The patient should be advised to keep one EpiPen in the home and one on his or her person at all times. Epinephrine is light sensitive and should be stored between 15o -30o C (59o -86o F).[4] Placement of an EpiPen in the car where internal summer temperatures can be well over 100o F is not recommended.
  • Oral H1 blockers (eg, diphenhydramine, hydroxyzine)
  • Corticosteroids (eg, prednisone, methylprednisolone)
Previous
Next

Transfer

  • Transfer the patient to the nearest facility capable of providing critical care monitoring if critical care monitoring cannot be performed at the facility initially treating the patient (in accordance with the current standards established by the Emergency Medical Treatment and Labor Act [EMTALA]).
  • A person capable of aggressively managing the patient's airway and monitoring and managing the patient's cardiopulmonary function should accompany the patient.
  • The transporter should have all the equipment and medication necessary to resuscitate the patient.
Previous
Next

Deterrence/Prevention

  • Teach the patient how to modify behavior, to dress, and to use toiletries and perfumes appropriately (see Activity).
  • Refer the patient to an allergist for desensitization to Hymenoptera venom. Desensitization by venom immunotherapy can be accomplished by the injection of depot extracts using a slow and conventional schedule, which minimizes local and systemic side effects, or it can be accomplished rapidly by using a rush protocol with aqueous extracts if protection needs to be achieved rapidly. However, the incidence of severe reactions makes the rush protocol less than ideal for an outpatient procedure and requires hospitalization.[5]
  • Up to 25% of patients who are on venom immunotherapy will still develop a severe anaphylactic reaction when re-stung.[5]
  • Prescribe auto-injectors (eg, EpiPen) and oral H1 blockers (eg, diphenhydramine, hydroxyzine).
Previous
Next

Complications

  • Consider local wound infection in any wasp sting site that worsens, persists, or partially resolves only to swell up with increased redness, swelling, or pain. Other symptoms and signs that should be elicited include fever, chills, red streaks extending proximally from the site, and purulent drainage from the site.
  • Wasp stings have also been associated with acute renal failure in children[6] as well as the Kounis syndrome or allergic myocardial ischemia and infarction.[7, 8]
Previous
Next

Prognosis

  • The prognosis for mild-to-moderate reactions is good.
  • The goal is prevention of another exposure.
Previous
Next

Patient Education

  • Teach the patient how to modify behavior, to dress, and to use toiletries and perfumes appropriately (see Activity and Outpatient Medication).
Previous
 
Contributor Information and Disclosures
Author

Carl A Mealie, MD, FACEP, FAAEM  Assistant Professor, Department of Emergency Medicine, Albert Einstein College of Medicine; Chief of Operations, Department of Emergency Medicine, Long Island Jewish Medical Center

Carl A Mealie, MD, FACEP, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physicians, American Medical Association, New York Academy of Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Alan S Multz, MD  Associate Professor of Clinical Medicine, Albert Einstein College of Medicine; Program Director, Internal Medicine Residency, Associate Chairman, Department of Medicine, Long Island Jewish Medical Center

Alan S Multz, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Astellas Pharmaceutical Honoraria Consulting; Merck Pharmaceutical Honoraria Speaking and teaching; The Medicines Company Honoraria Consulting; Schering Plough Honoraria Speaking and teaching; Wyeth Pharmaceuticals Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching

Max Vernon Wisgerhof II, MD  Fellowship Program Director, Department of Endocrinology and Metabolism, Henry Ford Hospital

Max Vernon Wisgerhof II, MD is a member of the following medical societies: American Thyroid Association and Endocrine Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Lisa Kirkland, MD, FACP, CNSP, MSHA  Assistant Professor, Department of Internal Medicine, Division of Hospital Medicine, Mayo Clinic; ANW Intensivists, Abbott Northwestern Hospital

Lisa Kirkland, MD, FACP, CNSP, MSHA is a member of the following medical societies: American College of Physicians, Society of Critical Care Medicine, and Society of Hospital Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. Apr 2000;53(4):273-6. [Medline].

  2. Diaz JH. The impact of hurricanes and flooding disasters on hymenopterid-inflicted injuries. Am J Disaster Med. Sep-Oct 2007;2(5):257-69. [Medline].

  3. Barach EM, Nowak RM, Lee TG, et al. Epinephrine for treatment of anaphylactic shock. JAMA. Apr 27 1984;251(16):2118-22. [Medline].

  4. EpiPen EpiPen JR [package insert]. NAPA California: Dey; 2009.

  5. Ruëff F, Przybilla B. Venom immunotherapy. Side effects and efficacy of treatment. Hautarzt. Mar 2008;59(3):200-5. [Medline].

  6. Vachvanichsanong P, Dissaneewate P. Acute renal failure following wasp sting in children. Eur J Pediatr. Aug 2009;168(8):991-4. [Medline].

  7. Rekik S, Andrieu S, Aboukhoudir F, Barnay P, Quaino G, Pansieri M, et al. ST Elevation Myocardial Infarction with No Structural Lesions after a Wasp Sting. J Emerg Med. Mar 26 2009;[Medline].

  8. Jairam A, Kumar RS, Ghosh AK, Hasija PK, Singh JI, Mahapatra D, et al. Delayed Kounis syndrome and acute renal failure after wasp sting. Int J Cardiol. Aug 13 2008;[Medline].

  9. Andrewes CH. The lives of Wasps and Bees. New York, NY: American Elsevier Publishing Co; 1969.

  10. Austen KF. Diseases of immediate sensitivity. In: Fauci AS, ed. Harrison's Principles of Internal Medicine. New York, NY: McGraw Hill; 1998:1860-1869.

  11. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. Mar 2004;113(3):536-42. [Medline].

  12. Boxer MB, Greenberger PA, Patterson R. The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs. Ann Allergy. Mar 1989;62(3):201-4. [Medline].

  13. Fadal RG. IgE-mediated hypersensitivity reactions. Otolaryngol Head Neck Surg. Sep 1993;109(3 Pt 2):565-78. [Medline].

  14. Golden DK. Immunology Allergy Clinics of North America. 2000;20(3):553-570. [Full Text].

  15. Hauk P, Friedl K, Kaufmehl K, et al. Subsequent insect stings in children with hypersensitivity to Hymenoptera. J Pediatr. Feb 1995;126(2):185-90. [Medline].

  16. Li JT, Yunginger JW. Management of insect sting hypersensitivity. Mayo Clin Proc. Feb 1992;67(2):188-94. [Medline].

  17. Muellman RL, Lindzon RD, Silvers NS. Allergy, hypersensitivity and anaphylaxis. In: Rosen P, ed. Emergency Medicine, Concepts and Clinical Practice. 4th ed. St. Louis, Mo: Mosby Year Book; 1998:2759-2776.

  18. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. Apr 2006;47(4):373-80. [Medline].

  19. Settipane GA, Boyd GK. Anaphylaxis from insect stings. Myths, controversy, and reality. Postgrad Med. Aug 1989;86(2):273-6, 278, 280-1. [Medline].

  20. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. Apr 2005;22(4):272-3. [Medline].

Previous
Next
 
A paper wasp (Randy Park, MD)
A paper wasp (Randy Park, MD)
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.